Comparison of EBER flow FISH results from two facilities
Cytometry Part B: Clinical Cytometry · 01.11.2026
DOI: 10.1002/cyto.b.70091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytometry Part B: Clinical Cytometry, online erschienen am 01.11.2026. Verfasst von Madoka Nishimura und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Developmental Biology, Institute of Science Tokyo, Tokyo, Japan. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Health, Labour and Welfare, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Epstein–Barr virus (EBV) primarily infects B cells but can occasionally target T and/or NK cells, leading to chronic active EBV disease or EBV‐associated hemophagocytic lymphohistiocytosis, which are often difficult to treat. EBV‐associated diseases exhibit a wide range of phenotypes. EBV‐infected cells play a major role in pathogenesis, making their identification essential for diagnosis. EBV‐encoded small RNA (EBER) flow fluorescence in situ hybridization (FISH), combined with multicolor flow cytometry, allows highly sensitive detection of EBV‐infected cells, even from limited samples. However, EBER flow FISH is labor‐intensive and requires technical expertise, limiting its use in standard facilities. We investigated whether the technique used in our department could be successfully implemented in other facilities. We performed EBER flow FISH at our department (Facility A) on cryopreserved peripheral blood mononuclear cell samples from seven patients diagnosed with EBV‐associated diseases. The same assay was then conducted at Facility B, and results were compared for cell populations and the frequency of EBER‐positive cells within each population. Significant correlations were observed between facilities for both cell fraction proportions and the proportion of EBER‐positive cells. Among data points where both facilities detected ≥5% EBER‐positive cells, 6 of 8 data points (75%) were within the acceptance interval of ±20%. Although one patient with very low proportions of EBER‐positive cells showed inconsistent findings, overall results did not differ significantly between facilities. Although further validation in larger multicenter studies is required, these findings suggest preliminary interlaboratory comparability and support the potential transferability of EBER flow FISH across institutions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics and Developmental Biology, Institute of Science Tokyo, Tokyo, Japan.
- Department of Pediatrics, Graduate School of Medical Sciences Kumamoto University, Kumamoto, Japan.
- IMSUT Clinical Flow Cytometry Laboratory, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- LSI Medience Corporation, Tokyo, Japan.
- Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan.
- Department of Pediatrics, National Defense Medical College (NDMC), Saitama, Japan.
ORCID-Profile: Hiroshi Yasui, Hirokazu Kanegane
Förderung
- Ministry of Health, Labour and Welfare
- Japan Agency for Medical Research and Development
Zitieren
APA
Nishimura, M., Tomomasa, D., Watanabe, E., Tsuchiya, K., Sato, N., Takachi, T., Imai, K., Akiyama, H., Ueki, M., Yoshifuji, K., Yasui, H., Tanita, K., Hoshino, A., & Kanegane, H. (2026). Comparison of EBER flow FISH results from two facilities. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.70091
Vancouver
Nishimura M, Tomomasa D, Watanabe E, Tsuchiya K, Sato N, Takachi T, et al. Comparison of EBER flow FISH results from two facilities. Cytometry Part B: Clinical Cytometry. 2026. doi:10.1002/cyto.b.70091
BibTeX
@article{Nishimura2026,
author = {Nishimura, Madoka and Tomomasa, Dan and Watanabe, Eri and Tsuchiya, Kazumi and Sato, Natsuko and Takachi, Takayuki and Imai, Kohsuke and Akiyama, Hiroki and Ueki, Masahiro and Yoshifuji, Kota and Yasui, Hiroshi and Tanita, Kay and Hoshino, Akihiro and Kanegane, Hirokazu},
title = {Comparison of EBER flow FISH results from two facilities},
journal = {Cytometry Part B: Clinical Cytometry},
year = {2026},
doi = {10.1002/cyto.b.70091}
}
EUVIMED